a<p>Odds ratio and its 95% confidence interval of the simple logistic regression in the univariate analysis.</p>b<p>Odds ratio and its 95% confidence interval of the multiple logistic regression for the Prognostic Score 1. R<sup>2</sup> = 0.54; 85 patients in the model.</p>c<p>Odds ratio and its 95% confidence interval of the multiple logistic regression for the Prognostic Score 2 (without inclusion of the Leishmania species). R<sup>2</sup> = 0.38; 85 patients in the model.</p>*<p>This variable was log-transformed before the analysis.</p>**<p>Odds ratio obtained after pooling <i>L. guyanensis</i> and <i>L. peruviana</i> and comparing against <i>L. brasiliensis</i>.</p
Neither parasitological nor molecular diagnosis of leishmaniasis Is widely available in clinical set...
Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary l...
INTRODUCTION:Reports of therapeutic failure to meglumine antimoniate (MA) and miltefosine in cutaneo...
The manuscript is relevant because of the finding of a new risk factor for chemotherapy failure and ...
<div><h3>Background</h3><p>Increased rates for failure in leishmaniasis antimony treatment have been...
Background: Increased rates for failure in leishmaniasis antimony treatment have been recently recog...
BackgroundTo date, there is no specific literature available on the determinants for therapeutic fai...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
<p>Mean and standard deviation (SD) or frequencies were compared between cured and failed cases to a...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
BACKGROUND: Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
<p>Multivariable logistic regression analysis of factors related to <i>Leishmania</i> parasite persi...
Background: Despite advances in diagnosis and treatment, leishmaniasis is now considered a severe pu...
BackgroundThe control of cutaneous leishmaniasis (CL) is facilitated by knowledge of factors associa...
<p>Unadjusted odds ratios for variables associated with anthroponotic cutaneous leishmaniasis in Kab...
Neither parasitological nor molecular diagnosis of leishmaniasis Is widely available in clinical set...
Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary l...
INTRODUCTION:Reports of therapeutic failure to meglumine antimoniate (MA) and miltefosine in cutaneo...
The manuscript is relevant because of the finding of a new risk factor for chemotherapy failure and ...
<div><h3>Background</h3><p>Increased rates for failure in leishmaniasis antimony treatment have been...
Background: Increased rates for failure in leishmaniasis antimony treatment have been recently recog...
BackgroundTo date, there is no specific literature available on the determinants for therapeutic fai...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
<p>Mean and standard deviation (SD) or frequencies were compared between cured and failed cases to a...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
BACKGROUND: Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
<p>Multivariable logistic regression analysis of factors related to <i>Leishmania</i> parasite persi...
Background: Despite advances in diagnosis and treatment, leishmaniasis is now considered a severe pu...
BackgroundThe control of cutaneous leishmaniasis (CL) is facilitated by knowledge of factors associa...
<p>Unadjusted odds ratios for variables associated with anthroponotic cutaneous leishmaniasis in Kab...
Neither parasitological nor molecular diagnosis of leishmaniasis Is widely available in clinical set...
Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary l...
INTRODUCTION:Reports of therapeutic failure to meglumine antimoniate (MA) and miltefosine in cutaneo...